Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Press Releases

Press Releases

posted on Jul 28, 2009 10:33PM

Why are so many people here concerned about PRs? We have had over 30 signings each with a PR and we still sit here at $0.12/share. It should be obvious to most that a PR from a penny stock that is an OTC Bulletin Board stock is not going to create a lot of buzz. Even if the markets were flying high instead of where they are now PTSC is not even on the radar. Let's realize there are a lot of bargains on the NYSE and AMEX and the OTC that have already started to recover from their lows. I know because I own a couple. I stay invested in PTSC (since 2003) because I believe in its long term potential.

What is going to draw the attention of investors is growing revenue and growing earnings per share over several Qs. Right now this is a highly speculative stock and given the economic and market conditions it is not an attractive investment. No amount of whinning about the board of directors nor personel attacks on members of this forum is going to change that. Some may find solace in conspiracy theories, as silly as most of them are, but they are all nonsense.

Back to lurking.

Share
New Message
Please login to post a reply